New Life Offers New, Non-Surgical Solution to Weight Loss
New Life Center for Bariatric Surgery is excited to share that the U.S. Food and Drug Administration has approved ORBERA™ to assist adult patients suffering from obesity – with a body mass index (BMI) of 30 to 40 – in losing and maintaining weight.
New Life Center for Bariatric Surgery and the Tennova Center for Surgical Weight Loss are among the first bariatric programs in the country to offer this procedure. Dr. Stephen Boyce, Medical Director of the Tennova Center for Surgical Weight Loss and New Life Center for Bariatric Surgery, is the only surgeon in east and middle Tennessee providing this new tool and program to help people achieve their weight loss goals.
ORBERA™ is a safe and effective weight loss solution with 20 years of global experience and real world results. More than 220,000 ORBERA™ balloons have been distributed worldwide in over 80 countries.
The ORBERA™ balloon is part of the ORBERA Managed Weight Loss System, a comprehensive, non-surgical two-part program that includes a balloon filling space in a patient’s stomach to reinforce proper portion control. Data on ORBERA™ collected in the U.S. clinical trial has shown that the average person lost 3.1 times the weight as compared with diet and exercise alone within six months.
Dr. Boyce recognizes that obesity is a chronic disease and is pleased to be able to offer new, minimally invasive solutions, like ORBERA™, to help transform the lives of East Tennessee patients before their disease progresses and requires more invasive treatment.
For additional information regarding ORBERA™, click here to visit our Orbera webpage or call 865-694-9676.